Date: 20/2/2008
Author: Fiona Tyndall
Source: The Australian Financial Review — Page: 35
Australian hearing device maker, Cochlear, expects to meet its earnings forecastfor 2007-08. It has posted revenue of $A298 million for the six months to 31December 2007, a rise of eight per cent. Its sales in the US were lower thanexpected, prompting a fall in its share price. Analysts believe that thecompany’s prospects are good, but there is not likely to be any trigger toimprove its share price in the short-term
Author: Fiona Tyndall
Source: The Australian Financial Review — Page: 35
Australian hearing device maker, Cochlear, expects to meet its earnings forecastfor 2007-08. It has posted revenue of $A298 million for the six months to 31December 2007, a rise of eight per cent. Its sales in the US were lower thanexpected, prompting a fall in its share price. Analysts believe that thecompany’s prospects are good, but there is not likely to be any trigger toimprove its share price in the short-term
Date: 14/2/2008
Author:
Source: The Australian Financial Review — Page: 34
The Australian dollar was fetching $US0.9040 early in European trading on 13February 2008, compared with $US0.9038 previously. The currency peaked at$US0.9085 amid reports that billionaire Warren Buffett may underwrite several USbond insurers. The dollar was also bolstered by growing speculation that therewill be another increase in Australian interest rates in March. The 15 per centrise in the value of the currency in the last year has affected the earnings oflisted companies such as Cochlear, which has a significant presence in overseasmarkets
Be the first to comment